| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.31 | 7e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.091 | 0.004 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.076 | 0.006 |